Skip to main content

Advertisement

Table 1 Baseline and intervention characteristics of the study groups

From: Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study

  Placebo (n = 30) TRF (n = 32)
  35-49 years > 50 years 35-49 years > 50 years
Age (years) 44.7 ± 0.9 a 59.1 ± 1.7 a 44.5 ± 1.0 b 56.1 ± 1.2 b
Blood pressure (mmHg)     
   Systolic     
Baseline (0 month) 121 ± 2.8 c 137 ± 3.6 c 121 ± 3.5 d 131 ± 3.3 d
3 months 123 ± 2.4 f 137 ± 5.1 f 121 ± 3.4 131 ± 3.5
6 months 120 ± 2.5 g 135 ± 5.0 g 122 ± 3.6 132 ± 3.3
   Diastolic     
Baseline (0 month) 75.4 ± 1.9 e 82.0 ± 2.7 e 80.6 ± 2.8 81.3 ± 2.6
3 months 73.7 ± 1.7 79.2 ± 2.9 79.2 ± 2.6 82.3 ± 2.6
6 months 75.7 ± 2.8 79.2 ± 3.3 79.0 ± 3.1 82.8 ± 1.9
Pulse (beat/minute)     
   Baseline (0 month) 73 ± 2 73 ± 3 70 ± 3 70 ± 2
   3 months 70 ± 2 72 ± 2 71 ± 3 71 ± 2
   6 months 71 ± 2 71 ± 3 69 ± 3 72 ± 2
Body mass index (kg/m2)     
   Baseline (0 month) 27.5 ± 1.2 26.3 ± 0.6 26.3 ± 0.7 27.7 ± 1.3
   3 months 27.5 ± 1.2 25.0 ± 1.0 25.6 ± 0.6 27.4 ± 1.2
   6 months 26.8 ± 1.2 25.2 ± 1.0 25.7 ± 0.7 27.1 ± 1.1
Fasting blood glucose (mmol/L)     
   Baseline (0 month) 5.53 ± 0.33 5.34 ± 0.13 5.74 ± 0.30 5.49 ± 0.10
   3 months 5.40 ± 0.44 5.37 ± 0.10 5.59 ± 0.22 5.24 ± 0.15
   6 months 5.55 ± 0.49 5.28 ± 0.14 5.42 ± 0.19 5.47 ± 0.11
  1. Values are expressed as mean ± SEM.
  2. Same letters indicate significant difference between 35-49 and > 50 year-old groups.
  3. a: p < 0.001, b: p < 0.001, c: p < 0.001, d: p < 0.05, e: p < 0.05, f: p < 0.001, g: p < 0.01